-
Product Insights
Open-Angle Glaucoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Open-Angle Glaucoma - Drugs In Development, 2023’, provides an overview of the Open-Angle Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Retinal Vascular Occlusion – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinal Vascular Occlusion - Drugs In Development, 2023’, provides an overview of the Retinal Vascular Occlusion pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Vascular Occlusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Retinal Vein Occlusion – Drugs In Development, 2023
Global Markets Direct’s, ‘Retinal Vein Occlusion - Drugs In Development, 2023’, provides an overview of the Retinal Vein Occlusion pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Vein Occlusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Optic Nerve Injury – Drugs In Development, 2023
Global Markets Direct’s, ‘Optic Nerve Injury - Drugs In Development, 2023’, provides an overview of the Optic Nerve Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Optic Nerve Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Herpetic Keratitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Herpetic Keratitis - Drugs In Development, 2023’, provides an overview of the Herpetic Keratitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Herpetic Keratitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Non-infectious Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Non-infectious Uveitis - Drugs In Development, 2023’, provides an overview of the Non-infectious Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Non-infectious Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Posterior Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Posterior Uveitis - Drugs In Development, 2023’, provides an overview of the Posterior Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Posterior Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Viral Keratitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Viral Keratitis - Drugs In Development, 2023’, provides an overview of the Viral Keratitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Viral Keratitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Fuchs Endothelial Corneal Dystrophy (FECD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Fuchs Endothelial Corneal Dystrophy (FECD) - Drugs In Development, 2023’, provides an overview of the Fuchs Endothelial Corneal Dystrophy (FECD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fuchs Endothelial Corneal Dystrophy (FECD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Anterior Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Anterior Uveitis - Drugs In Development, 2023’, provides an overview of the Anterior Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anterior Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...